title: Large induces functional glycans in an O-mannosylation dependent manner and targets GlcNAc terminals on alpha-dystroglycan.
abstract: Alpha-dystroglycan (α-DG) is a ubiquitously expressed receptor for extracellular matrix proteins and some viruses, and plays a pivotal role in a number of pathological events, including cancer progression, muscular dystrophies, and viral infection. The O-glycans on α-DG are essential for its ligand binding, but the biosynthesis of the functional O-glycans remains obscure. The fact that transient overexpression of LARGE, a putative glycosyltransferase, up-regulates the functional glycans on α-DG to mediate its ligand binding implied that overexpression of LARGE may be a novel strategy to treat disorders with hypoglycosylation of α-DG. In this study, we focus on the effects of stable overexpression of Large on α-DG glycosylation in Chinese hamster ovary (CHO) cell and its glycosylation deficient mutants. Surprisingly, stable overexpression of Large in an O-mannosylation null deficient Lec15.2 CHO cells failed to induce the functional glycans on α-DG. Introducing the wild-type DPM2 cDNA, the deficient gene in the Lec15.2 cells, fully restored the Large-induced functional glycosylation, suggesting that Large induces the functional glycans in a DPM2/O-mannosylation dependent manner. Furthermore, stable overexpression of Large can effectively induce functional glycans on N-linked glycans in the Lec8 cells and ldlD cells growing in Gal deficient media, in both of which circumstances galactosylation are deficient. In addition, supplement of Gal to the ldlD cell culture media significantly reduces the amount of functional glycans induced by Large, suggested that galactosylation suppresses Large to induce the functional glycans. Thus our results revealed a mechanism by which Large competes with galactosyltransferase to target GlcNAc terminals to induce the functional glycans on α-DG.
authors.affiliation: Neurology Department, McColl-Lockwood Laboratory for Muscular Dystrophy Research, Carolinas Medical Center, Charlotte, North Carolina, United States of America.
authors.forename: Yihong
authors.initials: Y
authors.lastname: Hu
authors.forename: Zhi-fang
authors.initials: ZF
authors.lastname: Li
authors.forename: Xiaohua
authors.initials: X
authors.lastname: Wu
authors.forename: Qilong
authors.initials: Q
authors.lastname: Lu
mesh_terms: D000117:Acetylglucosamine / Q000378:metabolism*; D000818:Animals; D016466:CHO Cells; D006224:Cricetinae; D003412:Cricetulus; D049030:Dystroglycans / Q000737:chemistry* / Q000378:metabolism*; D006031:Glycosylation; D006801:Humans; D008358:Mannose / Q000378:metabolism*; D008364:Mannosyltransferases / Q000235:genetics / Q000378:metabolism; D051379:Mice; D009154:Mutation; D017351:N-Acetylglucosaminyltransferases / Q000378:metabolism*; D009584:Nitrogen / Q000378:metabolism; D011134:Polysaccharides / Q000378:metabolism*; D011485:Protein Binding
chemical_list: D011134:Polysaccharides; D049030:Dystroglycans; C502747:Large1 protein, mouse; D008364:Mannosyltransferases; D017351:N-Acetylglucosaminyltransferases; D009584:Nitrogen; D008358:Mannose; D000117:Acetylglucosamine